Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
35.2M
-
Shares change
-
+163K
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
-$1.71M
-
Number of buys
-
45
-
Number of sells
-
-29
-
Price
-
$33.18
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q1 2021
88 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.2M shares
of 69M outstanding shares and own 51.1% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.66M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3.58M shares), Cormorant Asset Management, LP (3.2M shares), RA CAPITAL MANAGEMENT, L.P. (2.15M shares), WELLINGTON MANAGEMENT GROUP LLP (2.02M shares), VR Adviser, LLC (1.54M shares), BlackRock Inc. (1.45M shares), CITADEL ADVISORS LLC (1.43M shares), and Vivo Capital, LLC (1.24M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.